Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug ...
Read More
Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein
Read Less
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
PLEASE NOTE, WE DO NOT SHIP TO DENMARK. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from the UK.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Fine. Trade paperback (US). Glued binding. 184 p. Contains: Figures. Columbia / Ssrc Book (Privatization of Risk). In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Trade paperback (US). Glued binding. 184 p. Contains: Figures. Columbia / Ssrc Book (Privatization of Risk). In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
PLEASE NOTE, WE DO NOT SHIP TO DENMARK. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from the UK.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Editor(s): Light, Don. Series: Columbia / SSRC Book (Privatization of Risk). Num Pages: 184 pages, figures. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 208 x 142 x 11. Weight in Grams: 254. Series: Columbia / SSRC Book (Privatization of Risk). 184 pages, illustrations. Editor(s): Light, Don. Cateogry: (P) Professional & Vocational. BIC Classification: MMG. Dimension: 208 x 142 x 11. Weight: 254. 2010. Paperback.....We ship daily from our Bookshop.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. Ex-library. 167 p. : ill.; 22 cm. LCCN 2010009014 Type of material Book Main title The risks of prescription drugs / edited by Donald W. Light. Published/Created New York: Columbia University Press, c2010. Description 167 p. : ill.; 22 cm. ISBN 9780231146920 (cloth: alk. paper) 0231146922 (cloth: alk. paper) 9780231146937 (pbk. : alk. paper) 0231146930 (pbk. : alk. paper) LC classification RA401. A3 R57 2010 Related names Light, Donald, 1942-Contents Bearing the risks of prescription drugs / Donald Light--The Food and Drug Administration: inadequate protection from serious risks / Donald Light--The commercialization of medical decisions: physicians and patients at risk / Howard Brody--Pharmaceuticals and the medicalization of social life / Allan Horwitz--Medicalization and risk scares: the case of menopause and HRT / Cheryl Stults and Peter Conrad--Toward safer prescribing and better drugs / Donald Light. LC Subjects United States. Food and Drug Administration. Pharmaceutical policy--United States. Pharmaceutical industry--Risk management. Drugs--Risk assessment. Other Subjects Drug Industry--standards--United States. Prescription Drugs--standards--United States. Drug Toxicity--United States. Medication Errors--prevention & control--United States. Risk Assessment--United States. Notes Includes bibliographical references. Series The Columbia University Press and Social Science Research Council series on the privatization of risk A Columbia/SSRC book Columbia University Press and Social Science Research Council series on the privatization of risk. Columbia/SSRC book. Dewey class no. 338.4/76151 Geographic area code n-us---NLM class no. 2010 M-013 QV 736 R5955 2010 National bib agency no. 101525532 Other system no. (OCoLC)ocn540015686
